DK2996706T3 - Apolipoprotein-mimetika og anvendelser deraf - Google Patents
Apolipoprotein-mimetika og anvendelser derafInfo
- Publication number
- DK2996706T3 DK2996706T3 DK14769489.7T DK14769489T DK2996706T3 DK 2996706 T3 DK2996706 T3 DK 2996706T3 DK 14769489 T DK14769489 T DK 14769489T DK 2996706 T3 DK2996706 T3 DK 2996706T3
- Authority
- DK
- Denmark
- Prior art keywords
- applications
- apolipoprotein mimetics
- apolipoprotein
- mimetics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782956P | 2013-03-14 | 2013-03-14 | |
| US201361834992P | 2013-06-14 | 2013-06-14 | |
| PCT/US2014/027719 WO2014152776A1 (en) | 2013-03-14 | 2014-03-14 | Apolipoprotein mimetics and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2996706T3 true DK2996706T3 (da) | 2019-10-21 |
Family
ID=51581312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14769489.7T DK2996706T3 (da) | 2013-03-14 | 2014-03-14 | Apolipoprotein-mimetika og anvendelser deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160002315A1 (da) |
| EP (1) | EP2996706B1 (da) |
| JP (2) | JP6570511B2 (da) |
| AU (2) | AU2014239186B2 (da) |
| BR (1) | BR112015022624A2 (da) |
| CA (1) | CA2903869A1 (da) |
| DK (1) | DK2996706T3 (da) |
| ES (1) | ES2753381T3 (da) |
| IL (1) | IL240787B (da) |
| MX (1) | MX2015012818A (da) |
| NZ (1) | NZ713291A (da) |
| WO (1) | WO2014152776A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015298263B2 (en) | 2014-07-31 | 2020-05-14 | Anji Pharmaceuticals, Inc. | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
| WO2017120568A1 (en) * | 2016-01-08 | 2017-07-13 | Lipimetix Development, Inc. | Apoe mimetic peptide compositions |
| US20170233466A1 (en) * | 2016-02-17 | 2017-08-17 | Regeneron Pharmaceuticals, Inc. | Methods for Treating or Preventing Atherosclerosis by Administering an Inhibitor of ANGPTL3 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| GB9022788D0 (en) | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
| US5331573A (en) | 1990-12-14 | 1994-07-19 | Balaji Vitukudi N | Method of design of compounds that mimic conformational features of selected peptides |
| US5631280A (en) | 1995-03-29 | 1997-05-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6506880B2 (en) | 1998-03-17 | 2003-01-14 | The Uab Research Foundation | Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol |
| US7199102B2 (en) | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| AU2008296487A1 (en) | 2007-08-28 | 2009-03-12 | The Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| CN102917727B (zh) * | 2010-01-06 | 2017-10-17 | 康石医药科技（上海）有限公司 | Apoe肽及其用途 |
| AU2015298263B2 (en) * | 2014-07-31 | 2020-05-14 | Anji Pharmaceuticals, Inc. | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
-
2014
- 2014-03-14 CA CA2903869A patent/CA2903869A1/en not_active Abandoned
- 2014-03-14 NZ NZ713291A patent/NZ713291A/en not_active IP Right Cessation
- 2014-03-14 WO PCT/US2014/027719 patent/WO2014152776A1/en active Application Filing
- 2014-03-14 EP EP14769489.7A patent/EP2996706B1/en active Active
- 2014-03-14 DK DK14769489.7T patent/DK2996706T3/da active
- 2014-03-14 ES ES14769489T patent/ES2753381T3/es active Active
- 2014-03-14 AU AU2014239186A patent/AU2014239186B2/en not_active Ceased
- 2014-03-14 BR BR112015022624A patent/BR112015022624A2/pt not_active Application Discontinuation
- 2014-03-14 JP JP2016502527A patent/JP6570511B2/ja not_active Expired - Fee Related
- 2014-03-14 US US14/770,270 patent/US20160002315A1/en not_active Abandoned
- 2014-03-14 MX MX2015012818A patent/MX2015012818A/es active IP Right Grant
-
2015
- 2015-08-24 IL IL240787A patent/IL240787B/en active IP Right Grant
-
2017
- 2017-06-09 AU AU2017203911A patent/AU2017203911B2/en not_active Ceased
-
2019
- 2019-02-18 JP JP2019026743A patent/JP6772317B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2903869A1 (en) | 2014-09-25 |
| JP6570511B2 (ja) | 2019-09-04 |
| MX2015012818A (es) | 2016-05-12 |
| WO2014152776A1 (en) | 2014-09-25 |
| IL240787A0 (en) | 2015-10-29 |
| JP2016515137A (ja) | 2016-05-26 |
| AU2014239186A1 (en) | 2015-10-08 |
| AU2017203911B2 (en) | 2019-03-07 |
| EP2996706A1 (en) | 2016-03-23 |
| EP2996706A4 (en) | 2017-01-18 |
| JP2019089834A (ja) | 2019-06-13 |
| NZ713291A (en) | 2017-04-28 |
| JP6772317B2 (ja) | 2020-10-21 |
| EP2996706B1 (en) | 2019-07-31 |
| IL240787B (en) | 2019-07-31 |
| AU2014239186B2 (en) | 2017-04-20 |
| AU2017203911A1 (en) | 2017-06-29 |
| US20160002315A1 (en) | 2016-01-07 |
| ES2753381T3 (es) | 2020-04-08 |
| BR112015022624A2 (pt) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| DK3089994T3 (da) | Fabs-in-tandem-immunglobulin og anvendelser deraf | |
| DK3480213T3 (da) | Syntac-polypeptider og anvendelser deraf | |
| DK3192869T3 (da) | Isoleret oligonukleotid og anvendelse deraf i nukleinsyresekvensering | |
| DK2970460T3 (da) | Anti-IL-33-antistoffer og anvendelser deraf | |
| DK3027204T3 (da) | Flerdelte signaleringsproteiner og anvendelser deraf | |
| DK3052485T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK2963056T3 (da) | Insulinanalog og anvendelse deraf | |
| DK3336192T3 (da) | Rna-transskriptionsvektor og anvendelser deraf | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| DK2968173T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
| DK3030519T3 (da) | Tricykliske benzoxaborol-forbindelser og anvendelser deraf | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK2961835T3 (da) | Ny bakteriophag og antibakteriel sammensætning omfattende samme | |
| DK3046666T3 (da) | Multifunktionelle absorberende materialer og anvendelser deraf | |
| DK2807160T3 (da) | Antifibrotiske forbindelser og anvendelser deraf | |
| DK3058936T3 (da) | Peptidsammensætning og anvendelser deraf | |
| DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf |